Topic Hub
7 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 7 of 7 clinical reviews.
A detailed clinical guide to the Farxiga (dapagliflozin) alcohol interaction, covering DKA risk, hypoglycemia, dehydration, blood pressure effects, and safe drinking thresholds, reviewed by the HealthRX medical team.
Read clinical reviewShould you stop dapagliflozin (Farxiga) before a contrast-enhanced scan? Learn the AKI risk, exact hold protocols, and what evidence supports each recommendation.
Read clinical reviewA comprehensive clinical guide to the Farxiga (dapagliflozin) anesthesia and perioperative interaction, covering SGLT2 inhibitor-associated euglycemic DKA risk, FDA warnings, withholding protocols, and surgical glucose management.
Read clinical reviewA detailed clinical review of the dapagliflozin (Farxiga) and caffeine interaction profile, covering pharmacokinetics, blood glucose effects, hydration risks, and safety guidance for daily coffee drinkers on SGLT2 inhibitor therapy.
Read clinical reviewA clinical deep-dive into the Farxiga (dapagliflozin) and cannabis interaction profile, covering pharmacokinetic overlap, DKA risk amplification, blood-pressure effects, and safe-use guidance for patients using both.
Read clinical reviewA clinical deep-dive into the Farxiga (dapagliflozin) nicotine interaction profile, covering pharmacokinetic overlap, cardiovascular risk stacking, blood-pressure effects, and practical prescribing guidance for patients who smoke or use nicotine replacement.
Read clinical reviewA complete clinical guide to the Farxiga (dapagliflozin) vaccine interaction profile, covering immunogenicity data, alcohol use, drug interactions, and vaccination timing in SGLT2-inhibitor therapy.
Read clinical review